Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements

Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of nirsevimab and... | April 11, 2023

Related Keywords

Paris ,France General ,France ,United States ,Tarik Elgoutni ,Evan Berland ,Sandrine Guendoul ,Felix Lauscher ,Corentine Driancourt ,Eva Schaefer Jansen ,Nathalie Pham ,European Union ,Nasdaq ,Euronext ,Astrazeneca ,Collaboration Agreement ,Sanofi Stock Exchange ,News ,Information ,Press Release ,End ,Gobi ,Simplify ,Contractual ,Agreements ,Modification ,F ,Xisting ,Collaboration ,Agreement ,Ith ,Lives ,Sanofi ,Bull ,Commercial ,Control ,Irsevimab San Fr0000120578 ,